rapamycin

Immunosuppressive macrolide antibiotic with structural similarity to FK 506; inhibits T- and B-cell proliferation but at a much later stage than FK 506, despite binding to the same immunophilin. Inhibits TOR (target of rapamycin) in the Ras/MAP kinase signalling pathway.

rapamycin

A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamycin blocks certain white blood cells that can reject foreign tissues and organs. It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamycin is now c...
Found on http://www.cancer.gov/dictionary?expand=R

rapamycin

Immunosuppressive macrolide antibiotic with structural similarity to FK506, inhibits T and B-cell proliferation but at a much later stage than FK506, despite binding to the same immunophilin. Inhibits TOR (target of rapamycin) in the Ras/MAP kinase signalling pathway. ... (18 Nov 1997) ...
Found on http://www.encyclo.co.uk/local/20973

rapamycin

Rapamycin belongs to a group of medicines known as immunosuppressive agents. It is used to lower the body's natural immunity in patients who receive kidney transplants. When a patient receives an organ transplant, the body's white blood cells will try to get rid of (reject) the transplanted organ. Rapamycin works by preventing the white blood cells...
Found on http://www.encyclo.co.uk/local/21166
No exact match found